MA27306A1 - Ligands des recepteurs de la melanocortine. - Google Patents
Ligands des recepteurs de la melanocortine.Info
- Publication number
- MA27306A1 MA27306A1 MA27916A MA27916A MA27306A1 MA 27306 A1 MA27306 A1 MA 27306A1 MA 27916 A MA27916 A MA 27916A MA 27916 A MA27916 A MA 27916A MA 27306 A1 MA27306 A1 MA 27306A1
- Authority
- MA
- Morocco
- Prior art keywords
- receptor ligands
- melanocortine
- melanocortine receptor
- ligands
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37658502P | 2002-04-30 | 2002-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27306A1 true MA27306A1 (fr) | 2005-05-02 |
Family
ID=29401370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27916A MA27306A1 (fr) | 2002-04-30 | 2004-10-27 | Ligands des recepteurs de la melanocortine. |
Country Status (20)
Country | Link |
---|---|
US (2) | US7026335B2 (fr) |
EP (1) | EP1499588A1 (fr) |
JP (1) | JP2005525412A (fr) |
KR (1) | KR20040104672A (fr) |
CN (1) | CN1656070A (fr) |
AR (1) | AR039779A1 (fr) |
AU (1) | AU2003230923A1 (fr) |
BR (1) | BR0309744A (fr) |
CA (1) | CA2483787A1 (fr) |
IL (1) | IL164766A0 (fr) |
MA (1) | MA27306A1 (fr) |
MX (1) | MXPA04010761A (fr) |
NO (1) | NO20045136L (fr) |
NZ (1) | NZ536099A (fr) |
PE (1) | PE20040085A1 (fr) |
PL (1) | PL373695A1 (fr) |
RU (1) | RU2004134718A (fr) |
TW (1) | TW200409639A (fr) |
WO (1) | WO2003093234A1 (fr) |
ZA (1) | ZA200408529B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078717A1 (fr) | 2003-03-03 | 2004-09-16 | Merck & Co., Inc. | Derives de piperazine acylee tenant lieu d'agonistes du recepteur de la melanocortine-4 |
JP2005170803A (ja) * | 2003-12-08 | 2005-06-30 | Daicel Chem Ind Ltd | 新規なマロン酸モノメチル誘導体とその製造法 |
US20070021433A1 (en) | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
US8293900B2 (en) | 2005-09-29 | 2012-10-23 | Merck Sharp & Dohme Corp | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
CA2625877A1 (fr) | 2005-10-18 | 2007-04-26 | Merck & Co., Inc. | Derives de spiropiperidine acyles utilises en tant que modulateurs vis-a-vis du recepteur de melanocortine-4 |
TW200940523A (en) * | 2008-03-17 | 2009-10-01 | Gruenenthal Gmbh | Substituted sulfonamide derivatives |
PE20091731A1 (es) * | 2008-04-08 | 2009-11-11 | Gruenenthal Chemie | Derivados de sulfonamida sustituida |
WO2010056717A1 (fr) | 2008-11-17 | 2010-05-20 | Merck Sharp & Dohme Corp. | Amines bicycliques substituées pour le traitement du diabète |
WO2011011506A1 (fr) | 2009-07-23 | 2011-01-27 | Schering Corporation | Composés oxazépine spirocyclique en tant qu'inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase |
CA2768577A1 (fr) | 2009-07-23 | 2011-01-27 | Schering Corporation | Composes d?oxazepine benzofusionnes en tant qu?inhibiteurs de la coenzyme-stearoyle a delta-9 desaturase |
EP2563764B1 (fr) | 2010-04-26 | 2015-02-25 | Merck Sharp & Dohme Corp. | Nouveaux inhibiteurs de spiropipéridine prolylcarboxypeptidase |
WO2011143057A1 (fr) | 2010-05-11 | 2011-11-17 | Merck Sharp & Dohme Corp. | Inhibiteurs inédits de la prolylcarboxypeptidase |
US9006268B2 (en) | 2010-06-11 | 2015-04-14 | Merck Sharp & Dohme Corp. | Prolylcarboxypeptidase inhibitors |
CA2825098C (fr) | 2011-01-27 | 2020-03-10 | Universite De Montreal | Pyrazolopyridine et derives de pyrazolopyrimidine en tant que modulateurs du recepteur de la melanocortine-4 |
CN111072551A (zh) * | 2019-12-30 | 2020-04-28 | 上海睿瓦科技有限公司 | 催化氢化一步法制取哌啶胺的方法 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
HUT72076A (en) | 1992-12-11 | 1996-03-28 | Merck & Co Inc | Process for preparing spiro piperidines and homologs which promote release of growth hormone and pharmaceutical compositions containing them |
US5578593A (en) | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5783582A (en) | 1994-07-20 | 1998-07-21 | Merck & Co., Inc. | Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone |
US5767118A (en) | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
MX9709278A (es) | 1995-05-29 | 1998-03-31 | Pfizer | Dipeptidos que promueven la liberacion de la hormona de crecimiento, composiciones que los contienen y uso de los mismos. |
GB9612276D0 (en) | 1996-06-12 | 1996-08-14 | Merck & Co Inc | 4-Spiroindoline piperidines promote release of growth hormone |
US5804578A (en) | 1996-04-03 | 1998-09-08 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5877182A (en) | 1996-09-13 | 1999-03-02 | Merck & Co., Inc. | Piperidines promote release of growth hormone |
WO1998010653A1 (fr) | 1996-09-13 | 1998-03-19 | Merck & Co., Inc. | Piperidines, pyrrolidines et hexahydro-1h-azepines favorisant la secretion d'hormone de croissance |
US5965565A (en) | 1996-12-12 | 1999-10-12 | Merck & Co., Inc. | Piperidines promote release of growth hormone |
WO1999055679A1 (fr) | 1998-04-28 | 1999-11-04 | Trega Biosciences, Inc. | Composes a base d'isoquinoline tenant lieu de ligands de recepteurs de melanocortine et procedes d'utilisation |
AU757217B2 (en) | 1998-05-11 | 2003-02-06 | Helsinn Healthcare Sa | Compounds with growth hormone releasing properties |
CA2334551A1 (fr) | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Derives de spiropiperidine en tant qu'agonistes des recepteurs de la melanocortine |
US6294534B1 (en) | 1998-06-11 | 2001-09-25 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
EP1187614A4 (fr) | 1999-06-04 | 2005-06-22 | Merck & Co Inc | Piperidines substituees en tant qu'agonistes du recepteur de melanocortine-4 |
JP2003527444A (ja) | 2000-03-23 | 2003-09-16 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体 |
EP1268449A4 (fr) | 2000-03-23 | 2004-09-15 | Merck & Co Inc | Piperidines substituees en tant qu'agonistes du recepteur de la melanocortine |
AU6497701A (en) | 2000-05-30 | 2001-12-11 | Merck & Co Inc | Melanocortin receptor agonists |
PL360855A1 (en) | 2000-06-28 | 2004-09-20 | Pfizer Products Inc. | Melanocortin receptor ligands |
JP2004506687A (ja) | 2000-08-23 | 2004-03-04 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体作働薬としての置換ピペリジン類 |
EP1368340B1 (fr) | 2001-01-23 | 2005-08-10 | Eli Lilly And Company | Derives de piperazine agonistes du recepteur de la melanocortine |
CA2433025A1 (fr) | 2001-01-23 | 2002-08-01 | Chaoyu Xie | Piperidines/piperazines substituees utilisees comme agonistes du recepteur de melanocortine |
DE60219295T2 (de) | 2001-02-28 | 2008-01-03 | Merck & Co., Inc. | Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten |
WO2002068387A2 (fr) | 2001-02-28 | 2002-09-06 | Merck & Co., Inc. | Derives de piperidine acylatee utilises comme agonistes du recepteur de la melanocortine-4 |
JP2004532838A (ja) * | 2001-03-02 | 2004-10-28 | ブリストル−マイヤーズ スクイブ カンパニー | メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物 |
JP2005504043A (ja) | 2001-08-10 | 2005-02-10 | パラチン テクノロジーズ インク. | 生物学的に活性な金属ペプチド類のペプチド模倣体類 |
WO2003031410A1 (fr) | 2001-10-09 | 2003-04-17 | Neurocrine Biosciences, Inc. | Ligands de recepteurs de la melanocortine et compositions et methodes associees |
-
2003
- 2003-04-09 US US10/410,775 patent/US7026335B2/en not_active Expired - Fee Related
- 2003-04-11 PE PE2003000370A patent/PE20040085A1/es not_active Application Discontinuation
- 2003-04-16 AU AU2003230923A patent/AU2003230923A1/en not_active Abandoned
- 2003-04-16 EP EP03724030A patent/EP1499588A1/fr not_active Withdrawn
- 2003-04-16 IL IL16476603A patent/IL164766A0/xx unknown
- 2003-04-16 PL PL03373695A patent/PL373695A1/xx not_active Application Discontinuation
- 2003-04-16 JP JP2004501373A patent/JP2005525412A/ja active Pending
- 2003-04-16 BR BR0309744-7A patent/BR0309744A/pt not_active IP Right Cessation
- 2003-04-16 WO PCT/US2003/011536 patent/WO2003093234A1/fr active Application Filing
- 2003-04-16 CN CNA038121956A patent/CN1656070A/zh active Pending
- 2003-04-16 KR KR10-2004-7017452A patent/KR20040104672A/ko not_active Application Discontinuation
- 2003-04-16 MX MXPA04010761A patent/MXPA04010761A/es unknown
- 2003-04-16 CA CA002483787A patent/CA2483787A1/fr not_active Abandoned
- 2003-04-16 RU RU2004134718/04A patent/RU2004134718A/ru not_active Application Discontinuation
- 2003-04-16 NZ NZ536099A patent/NZ536099A/en unknown
- 2003-04-16 TW TW092108841A patent/TW200409639A/zh unknown
- 2003-04-29 AR ARP030101500A patent/AR039779A1/es not_active Application Discontinuation
-
2004
- 2004-10-21 ZA ZA200408529A patent/ZA200408529B/xx unknown
- 2004-10-27 MA MA27916A patent/MA27306A1/fr unknown
- 2004-11-25 NO NO20045136A patent/NO20045136L/no unknown
-
2005
- 2005-03-29 US US11/092,100 patent/US20050171158A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20045136L (no) | 2005-01-24 |
TW200409639A (en) | 2004-06-16 |
NZ536099A (en) | 2006-09-29 |
US20030236230A1 (en) | 2003-12-25 |
US20050171158A1 (en) | 2005-08-04 |
AR039779A1 (es) | 2005-03-02 |
PE20040085A1 (es) | 2004-04-15 |
BR0309744A (pt) | 2005-02-09 |
RU2004134718A (ru) | 2005-07-20 |
US7026335B2 (en) | 2006-04-11 |
ZA200408529B (en) | 2005-07-07 |
CA2483787A1 (fr) | 2003-11-13 |
AU2003230923A1 (en) | 2003-11-17 |
MXPA04010761A (es) | 2005-03-07 |
CN1656070A (zh) | 2005-08-17 |
IL164766A0 (en) | 2005-12-18 |
WO2003093234A1 (fr) | 2003-11-13 |
EP1499588A1 (fr) | 2005-01-26 |
PL373695A1 (en) | 2005-09-05 |
JP2005525412A (ja) | 2005-08-25 |
KR20040104672A (ko) | 2004-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053248D0 (no) | Kerosenblanding. | |
BR0313875B1 (pt) | escova de dentes. | |
BR0313318B1 (pt) | escova de dentes. | |
NO20052248D0 (no) | Svivelstykkesystem. | |
DE60305332D1 (de) | IMIDAZOi1,2-AöPYRIDINE | |
MA27306A1 (fr) | Ligands des recepteurs de la melanocortine. | |
NO20051500D0 (no) | Substituerte heterocyklylpyrimidiner. | |
BR0302168B8 (pt) | mÁquina de montagem. | |
NO20051497D0 (no) | Beta-laktamaseinhibitorprodrug. | |
ITMI20032170A1 (it) | Tagliacimosse. | |
ES1052590Y (es) | Quiosco-consigna. | |
ES1053405Y (es) | Porteria de waterpolo desmontable. | |
ES1053097Y (es) | Envase-expositor mejorado. | |
ES1051184Y (es) | Señalizador. | |
ES1052371Y (es) | Señalizador. | |
ES1052654Y (es) | Cubitera. | |
ES1052945Y (es) | Contraventana. | |
ES1052938Y (es) | Cantonera. | |
ES1052029Y (es) | Balin-proyectil. | |
ES1051110Y (es) | Caja-palet. | |
ES1052011Y (es) | Espetero. | |
ES1051605Y (es) | Cromo-puzzle. | |
ES1051703Y (es) | Potera. | |
ITTO20020864A1 (it) | Salvapolsino. | |
ITRE20020088A1 (it) | Parcheggiafacile. |